Navigation Links
A new disease: couch potato: needs drug therapy

Couch potato is a layman word for “Extreme laziness” which is a medical condition called motivational deficiency disorder (MoDeD). This was told by Australian researchers in a report in the 1 April issue of the British Medical Journal (BMJ) // Professor Leth Argos, a neuroscientist at the University of Newcastle, reportedly identified the new disorder.

In severe cases it can be fatal because the condition reduces the motivation to breathe, his report adds. It's diagnosed using a combination of positron emission tomography and low scores on a motivation rating scale, previously validated in elite athletes. Drug therapy involves treatment by various drugs.

An Australian biotechnology company called Healthtec, advised by Argos, has had promising trial results of the new drug indolebant, and designed to help people with the condition, as Moynihan "One young man who could not leave his sofa is now working as an investment adviser in Sydney."

Professor David Henry of the University of Newcastle says, “While some extreme sufferers of MoDeD may benefit from indolebant, common laziness is not a disease. Some people might have a genuinely debilitating form of MoDeD but others are just plain lazy and have "an absolute right to just sit there.”

Moynihan is critical of the role of Healthtec's promotion of MoDeD and what he calls the “corporate-sponsored creation of illness".

Moynihan says, “In almost any condition you take there are people at the severe end of the spectrum who benefit greatly from a medical label and from therapy including medication. I think that people who react negatively to this debate about disease mongering do a disservice to the genuinely ill."

'"/>




Page: 1

Related medicine news :

1. Stem cell cure for peripheral vascular disease: New hope on the horizon
2. Heart disease: Men Are From Mars, Women From Venus
3. Another dietary medicine for Alzheimer’s disease: Red cabbage
4. A potato (couch or not) in the diet adverse for diabetics.
5. Couch potato parents make couch potato kids!
6. Body mass index guide needs revision
7. Risk of heart disease prediction needs updating
8. Air pollution combined with greater medical needs
9. Treatment of postpartum depression needs to be personalized
10. FDA needs to be more vigilant in monitoring, tissue banks.
11. Australia: Salt needs More of Iodine
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/25/2017)... ... September 25, 2017 , ... ... and efficiency. The principle of First-Defect-Stop for laboratory weighing is designed ... have the chance to have negative consequences on downstream processes. , If a ...
(Date:9/25/2017)... (PRWEB) , ... September 25, 2017 , ... Physician Partners ... Fla. location at 5304 Main Street as an interventional pain management specialist. , ... and extremities. He joins PPOA from private practice In Brooksville, Fla. His orthopedic background ...
(Date:9/25/2017)... ... ... “Renew Refresh Restore Reward”: is a story of struggle and how trouble often happens ... Freeman, cofounded the Free Spirit Bible Church and currently serves as the church’s Director ... us to come over before the baby had to go back to her grandparents. ...
(Date:9/25/2017)... ... September 25, 2017 , ... The trend-spotters, tastemakers, and healthy lifestyle product experts ... based super herb drinks, with the new NEXTY Gold Award at the Natural Products ... the NEXTY Gold, which is reserved for just those companies that hit high marks ...
(Date:9/24/2017)... ... September 25, 2017 , ... Bhowanie Benimadhu’s new book “ Our ... questions of life and seeks answers in both Eastern and Western religious traditions and ... God is in the mind of humankind for the past thousands of years and ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... 6, 2017  Robert G. Szewc, M.D., is recognized ... in recognition of his contributions to the Medical field.  ... Nephrologist at the practice of Kidney and Hypertension Specialists, ... and hypertension solutions. He has worked in this position ... experience, as well as expertise in kidneys, hypertension, chronic ...
(Date:9/6/2017)...   PDI , a leader in infection prevention ... educational session focused on the role of chlorhexidine gluconate ... the 2017 Annual Scientific Meeting of the Association for ... the Phoenix Convention Center in ... will also feature PDI,s Prevantics® Device Swab ...
(Date:9/6/2017)... , Sept. 6, 2017 Eli Lilly and ... will present new data for galcanezumab and lasmiditan, two ... the International Headache Society (IHC) taking place Sept. 7-10 ... Lilly will highlight new, long-term data from an open-label ... of galcanezumab (120 mg and 240 mg) for the ...
Breaking Medicine Technology: